AMPA receptor subunit 1 (GluR‐A) knockout mice model the glutamate hypothesis of depression
- 20 May 2008
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 22 (9), 3129-3134
- https://doi.org/10.1096/fj.08-106450
Abstract
Recent evidence indicates that glutamate homeostasis and neurotransmission are altered in major depressive disorder, but the nature of the disruption and the mechanisms by which it contributes to the syndrome are unclear. Glutamate can act via AMPA, NMDA, or metabotropic receptors. Using targeted mutagenesis, we demonstrate here that mice with deletion of the main AMPA receptor subunit GluR-A represent a depression model with good face and construct validity, showing behavioral and neurochemical features of depression also postulated for human patients. GluR-A−/− mice display increased learned helplessness, decreased serotonin and norepinephrine levels, and disturbed glutamate homeostasis with increased glutamate levels and increased NMDA receptor expression. These results correspond well with current concepts regarding the role of AMPA and NMDA receptors in depression, postulating that compounds that augment AMPA receptor signaling or decrease NMDA receptor functions have antidepressant effects. GluR-A−/− mice represent a model to investigate the pathophysiology underlying the depressive phenotype and to identify changes in neural plasticity and resilience evoked by the genetic alterations in glutamatergic function. Furthermore, GluR-A−/− mice may be a valuable tool to study biological mechanisms of AMPA receptor modulators and the efficacy of NMDA antagonists in reducing behavioral or biochemical changes that correlate with increased helplessness.—Chourbaji, S., Vogt, M. A., Fumagalli, F., Sohr, R., Frasca, A., Brandwein, C, Hörtnagl, H., Riva, M. A., Sprengel, R., Gass, P. AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (GA427/8–1, SP602/ 2–1)
This publication has 34 references indexed in Scilit:
- Dynamic Regulation of Glutamatergic Postsynaptic Activity in Rat Prefrontal Cortex by Repeated Administration of Antipsychotic DrugsMolecular Pharmacology, 2008
- The NMDA Receptor as a Therapeutic Target in Major Depressive DisorderCNS & Neurological Disorders - Drug Targets, 2007
- AMPA Receptors in the Therapeutic Management of DepressionCNS & Neurological Disorders - Drug Targets, 2007
- The ascent of mouse: advances in modelling human depression and anxietyNature Reviews Drug Discovery, 2005
- Mice with Genetically Altered Glucocorticoid Receptor Expression Show Altered Sensitivity for Stress-Induced Depressive ReactionsJournal of Neuroscience, 2005
- Glutamate as a therapeutic target in psychiatric disordersMolecular Psychiatry, 2004
- Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major DepressionArchives of General Psychiatry, 2004
- An Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major DepressionAmerican Journal of Psychiatry, 2004
- Importance of AMPA Receptors for Hippocampal Synaptic Plasticity But Not for Spatial LearningScience, 1999
- Molecular biology of glutamate receptorsProgress in Neurobiology, 1994